Humanization and expression of IgG and IgM antibodies in plants as potential diagnostic reagents for Valley Fever
- PMID: 36119630
- PMCID: PMC9478164
- DOI: 10.3389/fpls.2022.925008
Humanization and expression of IgG and IgM antibodies in plants as potential diagnostic reagents for Valley Fever
Abstract
Monoclonal antibodies (mAbs) are important proteins used in many life science applications, from diagnostics to therapeutics. High demand for mAbs for different applications urges the development of rapid and reliable recombinant production platforms. Plants provide a quick and inexpensive system for producing recombinant mAbs. Moreover, when paired with an established platform for mAb discovery, plants can easily be tailored to produce mAbs of different isotypes against the same target. Here, we demonstrate that a hybridoma-generated mouse mAb against chitinase 1 (CTS1), an antigen from Coccidioides spp., can be biologically engineered for use with serologic diagnostic test kits for coccidioidomycosis (Valley Fever) using plant expression. The original mouse IgG was modified and recombinantly produced in glycoengineered Nicotiana benthamiana plants via transient expression as IgG and IgM isotypes with human kappa, gamma, and mu constant regions. The two mAb isotypes produced in plants were shown to maintain target antigen recognition to CTS1 using similar reagents as the Food and Drug Administration (FDA)-approved Valley Fever diagnostic kits. As none of the currently approved kits provide antibody dilution controls, humanization of antibodies that bind to CTS1, a major component of the diagnostic antigen preparation, may provide a solution to the lack of consistently reactive antibody controls for Valley Fever diagnosis. Furthermore, our work provides a foundation for reproducible and consistent production of recombinant mAbs engineered to have a specific isotype for use in diagnostic assays.
Keywords: IgG; IgM; Valley Fever (VF); coccidioidomycosis; diagnostics; humanization; plant-made diagnostics.
Copyright © 2022 Jugler, Grill, Eidenberger, Karr, Grys, Steinkellner, Lake and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis.Microbiol Spectr. 2022 Oct 26;10(5):e0257322. doi: 10.1128/spectrum.02573-22. Epub 2022 Sep 19. Microbiol Spectr. 2022. PMID: 36121238 Free PMC article.
-
Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody.Malar J. 2015 Feb 5;14:50. doi: 10.1186/s12936-015-0577-7. Malar J. 2015. PMID: 25651860 Free PMC article.
-
Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis.Pathogens. 2024 Jul 13;13(7):582. doi: 10.3390/pathogens13070582. Pathogens. 2024. PMID: 39057809 Free PMC article.
-
Tobacco against Ebola virus disease.Przegl Lek. 2015;72(10):567-71. Przegl Lek. 2015. PMID: 26946569 Review.
-
Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.Cancer Treat Res. 1990;51:413-32. doi: 10.1007/978-1-4613-1497-4_21. Cancer Treat Res. 1990. PMID: 1977458 Review.
Cited by
-
Artificial intelligence-driven systems engineering for next-generation plant-derived biopharmaceuticals.Front Plant Sci. 2023 Nov 15;14:1252166. doi: 10.3389/fpls.2023.1252166. eCollection 2023. Front Plant Sci. 2023. PMID: 38034587 Free PMC article. Review.
-
Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies.J Clin Microbiol. 2023 Sep 21;61(9):e0063123. doi: 10.1128/jcm.00631-23. Epub 2023 Sep 1. J Clin Microbiol. 2023. PMID: 37655868 Free PMC article.
-
Plant molecular farming: a promising frontier for orphan drug production.Biotechnol Lett. 2025 May 17;47(3):56. doi: 10.1007/s10529-025-03596-2. Biotechnol Lett. 2025. PMID: 40381123 Review.
-
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues.Front Immunol. 2023 Jun 8;14:1147960. doi: 10.3389/fimmu.2023.1147960. eCollection 2023. Front Immunol. 2023. PMID: 37359564 Free PMC article.
-
Efficient Expression of Functionally Active Aflibercept with Designed N-glycans.Antibodies (Basel). 2024 Apr 7;13(2):29. doi: 10.3390/antib13020029. Antibodies (Basel). 2024. PMID: 38651409 Free PMC article.
References
-
- Centers for Medicare and Medicaid Services and Department of Health and Human Services . 493.1256 Standard: Control procedures. CFR-42-493-1256 vol. 5 (2011).
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous